drugset / Trial / NCT00832689

Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer

NCT00832689 ↗

Phase 2 Completed 39 enrolled Yonsei University
Treatment

Summary

The study hypothesis is that chemotherapy of irinotecan and gemcitabine will improve local control of cancer and prolong survival in patients with inoperable biliary tract cancer.

Timeline

Start
2008-06
Primary completion
2010-02
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule — —
Subject Irinotecan Small molecule — —

Indications